Two shared instrumentation awards S10OD020056 and S10RR027050 to Columbia Center for Translational Immunology’s Flow Sorting Services supported research reported in over 60 publications, collectively authored by about hundred investigators. This recent paper states that a combination of allergenic lymphocyte infusion and a treatment to dislodge leukemia cells from the bone marrow decreases the likelihood of cancer relapse compared to the infusion alone.
Strategic Plan Section
Accelerating Research Discoveries by Providing Access to State-of-the-Art Instrumentation - Continue to accelerate research discoveries by providing access to state-of-the-art instrumentation